Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Capelli

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|July 2, 2010
Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methodsAnna Maria Capelli, Laura Castelletti, Cristian Salvagno, et al.
Respiratory Research|February 12, 2026
SPECT as a translational non-invasive method to assess occupancy of the tissue transglutaminase-2 by zampilimab in the mouse lungPierre-Simon Bellaye, Erica Ferrini, Michaël Claron, et al.
European Journal of Medicinal Chemistry|April 24, 2023
Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitorsRoberta Mazzucato, Marinella Roberti, Anna Maria Capelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2010
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptorsEzio Bettini, Anna Sava, Cristiana Griffante, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Chemmedchem|March 17, 2010
Triazolyl azabicyclo[3.1.0]hexanes: A class of potent and selective dopamine D(3) receptor antagonistsGiorgio Bonanomi, Simone Braggio, Anna Maria Capelli, et al.
Journal of Medicinal Chemistry|May 11, 2017
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted AnalogsAlessio Lodola, Serena Bertolini, Matteo Biagetti, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2010
Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonistsFabrizio Micheli, Romano Di Fabio, Angelo Giacometti, et al.
Journal of Medicinal Chemistry|June 22, 2024
Discovery and Optimization of Pyridazinones as PI3Kδ Selective Inhibitors for Administration by InhalationPaolo Bruno, Alessandra Micoli, Mauro Corsi, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-aDaniele Simoni, Riccardo Rondanin, Paolo Marchetti, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|July 2, 2010
Identification of novel alpha7 nAChR positive allosteric modulators with the use of pharmacophore in silico screening methodsAnna Maria Capelli, Laura Castelletti, Cristian Salvagno, et al.
Respiratory Research|February 12, 2026
SPECT as a translational non-invasive method to assess occupancy of the tissue transglutaminase-2 by zampilimab in the mouse lungPierre-Simon Bellaye, Erica Ferrini, Michaël Claron, et al.
European Journal of Medicinal Chemistry|April 24, 2023
Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitorsRoberta Mazzucato, Marinella Roberti, Anna Maria Capelli, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 3, 2010
Identification and characterization of novel NMDA receptor antagonists selective for NR2A- over NR2B-containing receptorsEzio Bettini, Anna Sava, Cristiana Griffante, et al.
British Journal of Pharmacology|January 15, 2011
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonistsAnna Maria Capelli, Laura Castelletti, Yu Hua Chen, et al.
Chemmedchem|March 17, 2010
Triazolyl azabicyclo[3.1.0]hexanes: A class of potent and selective dopamine D(3) receptor antagonistsGiorgio Bonanomi, Simone Braggio, Anna Maria Capelli, et al.
Journal of Medicinal Chemistry|May 11, 2017
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted AnalogsAlessio Lodola, Serena Bertolini, Matteo Biagetti, et al.
Bioorganic & Medicinal Chemistry Letters|November 9, 2010
Synthesis and pharmacological characterization of 5-phenyl-2-[2-(1-piperidinylcarbonyl)phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones: a new class of Neuropeptide S antagonistsFabrizio Micheli, Romano Di Fabio, Angelo Giacometti, et al.
Journal of Medicinal Chemistry|June 22, 2024
Discovery and Optimization of Pyridazinones as PI3Kδ Selective Inhibitors for Administration by InhalationPaolo Bruno, Alessandra Micoli, Mauro Corsi, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Synthesis and biological activity of a novel class nicotinic acetylcholine receptors (nAChRs) ligands structurally related to anatoxin-aDaniele Simoni, Riccardo Rondanin, Paolo Marchetti, et al.
Pageof 4